Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection

NCT00002051 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Thymopentin

Sponsor

Immunobiology Research Institute